I think if they get ONE approval (satisfying the FDA's demands re: manufacturing consistency and quality to ensure potency), they will get multiple/all of them eventually where there is a significant result shown.
New technology, new questions as to just how it works and just how we can be certain it will always do what MSB says it does, with the FDA making their standards for this new science up on the fly (while kids and < 65s are croaking daily, but hey...what can you do?).
We all know the FDA are a bunch of hypocritical POSs, what with that recent Alzheimer's disease debacle, and the resignation of a number of their experts as fallout from their clearly corrupt decision, but they are doing here what they are supposed to be doing always (albeit what they fail to do in most other cases it seems...).
Assuming that Rem-L and Rex-L are manufactured using the same techniques/technology/potency assays, etc., presumably even in the same facilities and by the same MSB/Lonza team members, all that SHOULD matter is what the RCT results indicate the MSCs can accomplish.
I will likely buy a bit more under 1.40-50 as well if it goes down there, may as well keep averaging down. Salve for my bruised ego and pocketbook...
- Forums
- ASX - By Stock
- MSB
- FY22 - It's all to play for here!
FY22 - It's all to play for here!, page-11
-
- There are more pages in this discussion • 135 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.46 |
Change
0.015(1.04%) |
Mkt cap ! $1.661B |
Open | High | Low | Value | Volume |
$1.44 | $1.46 | $1.40 | $3.815M | 2.664M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 11031 | $1.45 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.46 | 14844 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 11031 | 1.450 |
1 | 17000 | 1.440 |
5 | 100670 | 1.435 |
4 | 42962 | 1.430 |
2 | 30429 | 1.425 |
Price($) | Vol. | No. |
---|---|---|
1.455 | 10289 | 1 |
1.460 | 93336 | 5 |
1.465 | 31016 | 2 |
1.470 | 32929 | 2 |
1.475 | 36108 | 1 |
Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
Featured News
SBW
Shekel Brainweigh reports a 50% revenue increase in its Retail Innovation suite and delivers the first batch of 20 Smart Bays to Hitachi as part of a larger order
BM8
Learn of the ASX-listed company that is well-placed to respond to the future global energy demand
MSB (ASX) Chart |
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
SPONSORED BY The Market Online